Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-04-23
1990-09-25
Weimar, Elizabeth C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514912, 435 691, A61K 3736, C12P 2102
Patent
active
049593536
ABSTRACT:
A method for treating corneal stromal wounds to promote regeneration of the affected tissue is provided. This method employs recombinant human epidermal growth factor.
REFERENCES:
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4588684 (1986-05-01), Brake
patent: 4708861 (1987-11-01), Popescu et al.
Albrecht v. Graefes Arch klin exp Ophthal (1979), 210:159-65.
Carpenter, Handbook of Exp. Pharmacology, vol. 57:90-132 (1981).
Urdea et al., PNAS, 80:7461-7465 (Dec. 1983).
Rothstein et al., Meth. Enzy. 68:98-109 (1979).
Bennetzen et al., J. Biol Chem. 257(6): 3026-3031 (Mar. 25, 1982).
Fabricant et al., Arch. Opthalmol., 100:994-995 (1982).
Kurjan et al., Cell, 90:933-943 (Oct. 1982).
Greaves, Clin. Exp. Dermatol., 5:101-103 (1980).
Brown Gregory L.
Eiferman Richard
Schultz Gregory L.
Valenzuela Pablo D. T.
Chiron Corporation
Knode Marian C.
University of Louisville Foundation
Weimar Elizabeth C.
LandOfFree
Promotion of corneal stroma wound healing with human epidermal g does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Promotion of corneal stroma wound healing with human epidermal g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Promotion of corneal stroma wound healing with human epidermal g will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-329117